Economic Evaluation for Palbociclib Plus Fulvestrant vs Ribociclib Plus Fulvestrant and Abemaciclib Plus Fulvestrant in Endocrine-Resistant Advanced or Metastatic Breast Cancer in Italy

• Main Authors: Colombo GL (Author), Valentino MC (Author), Fabi A (Author), Dieci MV (Author), Caruggi M (Author), Bruno GM (Author), Lombardi G (Author), Di Matteo S (Author)
• Format: Book
• Published: Dove Medical Press, 2023-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Giorgio Lorenzo Colombo,1 Maria Chiara Valentino,2 Alessandra Fabi,3 Maria Vittoria Dieci,4,5 Mauro Caruggi,2 Giacomo Matteo Bruno,2 Gloria Lombardi,6 Sergio Di Matteo2 1Department of Drug Sciences, University of Pavia, Pavia, Italy; 2S.A.V.E. Studi Analisi Valutazioni Economiche S.r.l., Health Econ...